The Therapeutic Potential of the Anticancer Activity of Fucoidan: Current Advances and Hurdles

Jun-O Jin1,2,3, Pallavi Singh Chauhan4, Ananta Prasad Arukha5

  • 1Shanghai Public Health Clinical Center & Institutes of Biomedical Sciences, Shanghai Medical College, Fudan University, Shanghai 201508, China.

Marine Drugs
|June 2, 2021
PubMed

Insights

Fucoidan, a compound from brown algae, shows promise as an anticancer agent by slowing tumor growth and enhancing chemotherapy. It also protects healthy tissues from drug damage.

Area of Science:

  • Marine natural products
  • Cancer biology
  • Pharmacology

Background:

  • Cancer cells share common behaviors, making them targets for chemotherapy.
  • Chemotherapy drugs can harm healthy tissues, necessitating protective agents.
  • Fucoidan, a sulfated polysaccharide from brown algae, exhibits significant anticancer properties.

Purpose of the Study:

  • To review the anticancer mechanisms of fucoidan.
  • To explore fucoidan's synergistic effects with chemotherapy.
  • To discuss challenges in developing fucoidan as an anticancer drug.

Main Methods:

  • Literature review of studies on fucoidan's anticancer activities.
  • Analysis of fucoidan's effects on cancer cell cycle and apoptosis.
  • Investigation of fucoidan's immunomodulatory effects.
  • Examination of fucoidan's protective effects against chemotherapy and radiation toxicity.

Main Results:

  • Fucoidan induces cell cycle arrest and apoptosis in cancer cells.
  • Fucoidan stimulates cytotoxic natural killer cells and macrophages.
  • Fucoidan mitigates toxicity from chemotherapy and radiation.
  • Fucoidan demonstrates synergistic effects when combined with anticancer drugs.

Conclusions:

  • Fucoidan possesses multifaceted anticancer mechanisms, including direct tumor cell killing and immune system modulation.
  • Fucoidan shows potential as a therapeutic agent to enhance conventional cancer treatments and reduce side effects.
  • Further research and development are needed to overcome obstacles for fucoidan's clinical application.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.0K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.3K
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
2.1K